글로벌 전두측두 장애 치료 시장 – 2029년까지의 산업 동향 및 예측

전두측두 장애 치료 시장 분석 및 규모

전두측두엽 장애 치료 시장은 예측 기간 동안 상당한 성장을 보일 것으로 예상됩니다. 전두측두엽 퇴화는 주로 뇌의 측두엽과 전두엽에 손상을 직접 일으키는 단백질인 TDP43과 타우에 의해 유발됩니다. 전두측두엽 장애의 원인은 아직 알려지지 않았지만, 주로 40~60세 연령대에 영향을 미칩니다. COVID-19도 시장 성장에 큰 영향을 미쳤습니다.

Data Bridge Market Research는 2022-2029년 예측 기간 동안 글로벌 전두측두 장애 치료 시장의 성장률을 분석합니다. 글로벌 전두측두 장애 치료 시장의 예상 CAGR은 언급된 예측 기간 동안 약 4.50%인 경향이 있습니다. 이 시장은 2021년에 3억 5천만 달러로 평가되었으며 2029년까지 4억 9천 7백 74만 달러까지 성장할 것입니다. 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

시장 정의

전두측두엽 장애는 전두측두엽 변성으로도 알려져 있으며, 주로 뇌의 전두엽과 측두엽에 영향을 미치는 뇌 장애입니다. 일반적으로 진행성 신경 세포 손실과 치매가 특징입니다. 전두측두엽 장애의 발병 평균 연령은 40~60세이지만 60세 이후에 시작될 수도 있으며, 진단 후 최대 수명은 8~10년입니다. 이는 의료 분야에 매우 중요하므로 예측 기간 동안 크게 증가할 것으로 예상됩니다.

전두측두엽 장애 치료 시장 범위 및 세분화

Global Frontotemporal Disorders Treatment Market Dynamics

Drivers

• Increasing FTD Drug Development and Increasing Funds

Non-profit organizations and disease advocacy & private organizations presently are focusing on supporting FTD drug development as the patient population is expanding. Research funding initiatives by several non-profit organizations such as the Association for Frontotemporal Degeneration (AFTD), Bluefield Project Organization, Tau Consortium Organization, Alzheimer Discovery Foundation (ADDF), and CurePSP, Inc. have facilitated to stimulate research initiatives in frontotemporal disorders treatment drugs. These organizations support clinical as well as preclinical trials for testing novel therapeutics that are interventional to either slow or stop FTD and other rare neurological disease progressions. This boosts the market growth.

• Rising Demand for Oral Drugs

Oral drugs is expected to boost the market growth. The segment is expected to accelerate the global market as most products are available in capsule and tablet form and it is a very feasible route of administration.

Opportunities

• Increase in Elderly Population

Increasing life expectancy rate is another main factor expected to boost the frontotemporal disorders treatment market growth because of the high incidence of neurological disease among the elderly population. People aged 65 years and above are typically susceptible to neurodegenerative diseases such as frontotemporal disorder, Alzheimer’s, and dementia. Thus, this population demands better treatment options and as a result create opportunities for the market growth.

• Higher Drug Approvals and Advanced Treatment

Several antidepressant drugs are used for the treatment of major depressive disorders and other conditions, such as dysthymia, obsessive-compulsive disorder (OCD), anxiety disorders, eating disorders, chronic pain, neuropathic pain. For instance, in October 2018, Lundbeck launched Brintellix tablets that are used for treating Major Depressive Disorder in India. Likewise, in April 2019, Lupin has launched antidepressant Fluoxetine tablets in the American market. The tablets are specified for the treatment of the major depressive disorder, obsessive-compulsive disorder. Thus, these policies drive the market growth.

Restraints/Challenges

• Misdiagnosis of Neurological Disorders

Several frontotemporal disorders are often misdiagnosed as depression, Parkinson’s, Alzheimer’s, or other psychiatric conditions, thus limiting the possibility of adopting neurological conditions treatment.

• Drug Trial Failures

Even though clinical trials have resulted in numerous interventions other than medications, the continuous high rate of clinical trial failures is a major factor that impels the growth prospects of neurological conditions treatment. Thus, it limits the growth of the market.

This global frontotemporal disorders treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global frontotemporal disorders treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Frontotemporal Disorders Treatment Market      

The COVID-19 pandemic deeply damaged the frontotemporal disorders treatment market. An upsurge in infection fear among people of all ages has resulted from the growing rate of COVID-positive cases that have resulted in mortality and morbidity worldwide. In addition, the pandemic limits on travel and movement, and hospital beds reserved for COVID patients reduced clinical and hospital visits.

Though, the arrival of virtual healthcare consultations and remote patient monitoring, as well as the rise in COVID-19 vaccines and lifting of lockdown limitations, will allow the market for frontotemporal disorders treatment devices to quickly recover and grow majorly during the coming years. As a result, the market is projected to grow at a fast pace during the forecast period.

Global Frontotemporal Disorders Treatment Market Scope

The global frontotemporal disorders treatment market is segmented on the drug class, treatment, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Drug Class

• Antidepressants
• Selective serotonin reuptake inhibitors
• Serotonin and noradrenaline reuptake inhibitors
• Antipsychotics
• RIsperidone
• Quetiapine
• Others

Treatment

• Behavioral Symptoms Management
• Psychological Symptoms Management

Route of Administration

• Oral
• Parenteral

End-Users

• Hospitals
• Homecare
• Speciality Centres
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

 Frontotemporal Disorders Treatment Market Regional Analysis/Insights

The global frontotemporal disorders treatment market is analyzed and market size insights and trends are provided by drug class, treatment, route of administration, distribution channel and end-user as referenced above.

The major countries covered in the global frontotemporal disorders treatment market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is expected to have the highest market growth due to the high-income of the countries and advanced healthcare facilities.

Asia-Pacific dominates the market due to the increase government initiatives and presence of generic companies.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Frontotemporal Disorders Treatment Market Share Analysis

글로벌 전두측두장애 치료 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우세입니다. 제공된 위의 데이터 포인트는 글로벌 전두측두장애 치료 시장과 관련된 회사의 초점에만 관련이 있습니다.

글로벌 전두측두엽 장애 치료 시장에서 활동하는 주요 기업은 다음과 같습니다.

• Teva Pharmaceutical Industries Ltd(이스라엘)
• 마일런 NV(미국)
• 존슨앤존슨 서비스 주식회사(미국)
• F. 호프만-라 로슈 유한회사(스위스)
• 릴리(미국)
• 머크앤코(미국)
• Aurobindo Pharma(인도)
• 브리스톨-마이어스 스퀴브 회사(미국)
• GSK plc (영국)
• Ascendis Pharma A/S(덴마크)
• 루팡(인도)
• 히크마 제약(영국)

SKU-54444